… obstructive pulmonary disease, peripheral artery disease, left ventricular ejection fraction,
estimated glomerular filtration rate, SYNTAX score, number of diseased vessels beyond the …

… with left main coronary artery disease of low or intermediate anatomical complexity to undergo
either percutaneous coronary … cobalt–chromium everolimus-eluting stents (PCI group, 948 …

… left main coronary artery disease (LMCAD) is controversial. Coronary artery bypass graft
surgery … CABG with percutaneous coronary intervention (PCI) with drug-eluting stents (DES) …

… Everolimus-eluting stents or bypass surgery for left main coronary artery disease. … The
3-vessel disease cohort of the SYNTAX trial 32 and 2 randomized clinical trials 33 ,34 of patients …

… ischemic risk, coronary artery bypass grafting (CABG) has … for unprotected left main coronary
artery (LMCA) disease (1,2). … coronary intervention (PCI), involving drug-eluting stents (DES)…

… coronary intervention with drug-eluting stents and coronary-artery bypass grafting for left
main coronary artery disease … than after CABG in patients with left main and 3-vessel disease. …

… results of arterial grafting and by the potential protective effect of arterial grafting in prevention
… involving the left anterior descending and left circumflex coronary arteries are technically …

… coronary intervention (PCI) with drug-eluting stents compared with coronary artery bypass
graft (CABG) for LM disease… of patients, whereas 3-vessel disease was present in about 20% …

… disease (isolated LM: 17%; LM and single-vessel disease: 22%; LM and 2-vessel disease:
29%; LM and 3-vessel disease: … of stents versus bypass surgery for left main coronary artery …

… stents and about 40% of patients had two-vessel disease, and no patients with left main
coronary artery disease … included only patients with left main coronary artery disease (n=105), 10-…